Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma | British Journal of Cancer
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-1-full.png "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
PDF) Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text
Results of the meta-analysis of the diagnostic markers for colorectal... | Download Table
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology | SpringerLink
Colorectal Cancer Antibodies used in Immunohistochemistry | LSBio
Immunohistochemical‑based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial‑mesenchymal transition
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis | Cancer Cell International | Full Text
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer - ScienceDirect
An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer | BMC Cancer | Full Text
